These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6486)

  • 1. Synthetic MIF has no effect on beta-MSH and ACTH hypersecretion in Nelson's syndrome.
    Donnadieu M; Laurent MF; Luton JP; Bricaire H; Girard F; Binoux M
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1145-8. PubMed ID: 6486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of ACTH secretion by synthetic MSH-release inhibiting factor Pro-Leu-Gly-NH2 in Addison's disease.
    Voigt KH; Fehm HL; Lang RE; Beinert KE; Pfeiffer EF
    Horm Metab Res; 1977 Mar; 9(2):150-2. PubMed ID: 16818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.
    Reincke M; Allolio B; Kaulen D; Jaursch-Hancke C; Winkelmann W
    Klin Wochenschr; 1988 Aug; 66(15):686-9. PubMed ID: 2845188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a radioimmunoassay for peptides related to beta-melanocyte-stimulating hormone in human plasma: the lipotropins.
    Gilkes JJ; Bloomfield GA; Scott AP; Lowry PJ; Ratcliffe JG; Landon J; Rees LH
    J Clin Endocrinol Metab; 1975 Mar; 40(3):450-7. PubMed ID: 46869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive beta-MSH in human plasma and in a corticotrophic adenoma culture medium. Its relation to the lipotrophins.
    Bertagna X; Donnadieu M; Seurin D; Binoux M; Girard F
    Acta Endocrinol (Copenh); 1979 Jan; 90(1):8-17. PubMed ID: 216210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal and abnormal regulation of beta-msh in man.
    Abe K; Nicholson WE; Liddle GW; Orth DN; Island DP
    J Clin Invest; 1969 Aug; 48(8):1580-5. PubMed ID: 4307702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion.
    Ambrosi B; Bochicchio D; Riva E; Faglia G
    J Endocrinol Invest; 1983 Aug; 6(4):305-6. PubMed ID: 6315806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.
    Loli P; Berselli ME; Frascatani F; Muratori F; Tagliaferri M
    J Endocrinol Invest; 1984 Apr; 7(2):93-6. PubMed ID: 6327800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant secretion of Y-MSH with ACTH and beta-endorphin in humans.
    Nakao K; Oki S; Tanaka I; Nakai Y; Imura H
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1205-7. PubMed ID: 6252236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ovine corticotrophin releasing factor (oCRF), bromocriptine and TRH on the secretion of ACTH and alpha-MSH in Nelson's syndrome and Cushing's disease.
    Abraham RR; Campbell EA; Gillham B; Thody AJ; Altaher AR; Prysor-Jones A; Wynn V; Jones MT; Jenkins J
    Clin Endocrinol (Oxf); 1986 Jul; 25(1):75-85. PubMed ID: 3024873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.
    Motomatsu T; Takahashi H; Ibayashi H; Nobunaga M
    J Clin Endocrinol Metab; 1984 Sep; 59(3):495-8. PubMed ID: 6086700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of ACTH to octreotide in a probable corticotropic adenoma associated with Addison's disease.
    Suárez-Llanos JP; Fernández-Fernández E; Checa MR; Jara-Albarrán A
    Neuro Endocrinol Lett; 2007 Oct; 28(5):549-53. PubMed ID: 17984930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive bioassay for the determination of human plasma ACTH levels.
    Liotta A; Krieger DT
    J Clin Endocrinol Metab; 1975 Feb; 40(2):268-7. PubMed ID: 165419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotrophic and melanotrophic functions in congenital adrenal hyperplasia.
    Lombardi G; Oliver Ch; Lupoli G; Minozzi M
    Acta Endocrinol (Copenh); 1977 May; 85(1):118-25. PubMed ID: 16424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of sodium valproate in the treatment of Nelson's syndrome.
    Dornhorst A; Jenkins JS; Lamberts SW; Abraham RR; Wynn V; Beckford U; Gillham B; Jones MT
    J Clin Endocrinol Metab; 1983 May; 56(5):985-91. PubMed ID: 6300181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatographic characterization of adsrenocorticotrophin in human plasma.
    Ratter SJ; Lowry PJ; Besser GM; Rees LH
    J Endocrinol; 1980 Jun; 85(3):359-69. PubMed ID: 6251148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New evidence that demonstrates that L-pro-L-leu-L-gly-NH2 might be the natural MIF.
    Vivas A; Celis ME
    Acta Physiol Lat Am; 1977; 27(4):177-82. PubMed ID: 31762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay of beta-MSH in human plasma and tissues.
    Abe K; Nicholson WE; Liddle GW; Island DP; Orth DN
    J Clin Invest; 1967 Oct; 46(10):1609-16. PubMed ID: 4294052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.